The incidence of potential medication interactions including herbs and supplements among breast and prostate cancer patients during and after systemic anticancer therapy.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 9028-9028
Author(s):  
N. Kwon ◽  
R. T. Lee ◽  
M. Ray ◽  
R. Z. Szmulewitz ◽  
J. H. Von Roenn ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Anticancer Therapy ◽  
Breast And Prostate Cancer

scholarly journals Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients

2006 ◽  
Vol 118 (2) ◽  
pp. 518-520 ◽  
Author(s):  
Kirsi Syrjäkoski ◽  
Henna Fredriksson ◽  
Tarja Ikonen ◽  
Tuula Kuukasjärvi ◽  
Ville Autio ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Gene Mutations ◽  
Male Breast ◽  
Hemochromatosis Gene ◽  
Breast And Prostate Cancer

scholarly journals Jaw complications in breast and prostate cancer patients treated with zoledronic acid

2006 ◽  
Vol 45 (2) ◽  
pp. 216-217 ◽  
Author(s):  
C. Ortega ◽  
R. Faggiuolo ◽  
R. Vormola ◽  
F. Montemurro ◽  
D. Nanni ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Zoledronic Acid ◽  
Cancer Patients ◽  
Breast And Prostate Cancer

scholarly journals Skeletal-Related Events among Breast and Prostate Cancer Patients: Towards New Treatment Initiation in Malaysia's Hospital Setting

2013 ◽  
Vol 14 (5) ◽  
pp. 3357-3362 ◽  
Author(s):  
Sharifa Wan Puteh Ezat ◽  
Syed Mohamed Aljunid Syed Junid ◽  
Noraziani Khamis ◽  
Zafar Ahmed ◽  
Saperi Sulong ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Treatment Initiation ◽  
Hospital Setting ◽  
Skeletal Related Events ◽  
Breast And Prostate Cancer ◽  
New Treatment

scholarly journals Plasma Lipidomic Profiles of Kidney, Breast, and Prostate Cancer Patients Differ from Healthy Controls

2021 ◽  
Author(s):  
Denise Wolrab ◽  
Robert Jirásko ◽  
Ondřej Peterka ◽  
Jakub Idkowiak ◽  
Michaela Chocholoušková ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Clinical Medicine ◽  
Tumor Stage ◽  
Blood Analysis ◽  
Blood Collection ◽  
Healthy Controls ◽  
Lipid Species ◽  
Breast And Prostate Cancer ◽  
Sensitivity Specificity

Abstract Early cancer screening is one of the unmet needs in clinical medicine. The peripheral blood analysis is a preferred method for efficient population screening as blood collection is well embedded in clinical practice and minimally invasive for patients. Lipids are important biomolecules, and variations in lipid concentrations may reflect pathological disorders. The lipidomic profiling by ultrahigh-performance supercritical fluid chromatography hyphenated to mass spectrometry of human plasma for distinguishing samples obtained from breast, kidney, and prostate cancer patients and healthy controls is investigated. The mean sensitivity, specificity, and accuracy of the new lipidomic profiling approach were 85%, 95%, and 92% for kidney cancer; 91%, 97%, and 94% for breast cancer; and 87%, 95%, and 92% for prostate cancer. No association of statistical models with tumor stage is observed. The statistically most significant lipid species for differentiation of studied cancer types are CE 16:0, Cer 42:1, LPC 18:2, PC 36:2, PC 36:3, SM 32:1, and SM 41:1.

Sign in / Sign up

Export Citation Format

Share Document